BARCLAYS PLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 149 filers reported holding KURA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,416
+9.5%
155,245
+27.0%
0.00%0.0%
Q2 2023$1,293
-53.5%
122,267
-46.2%
0.00%0.0%
Q1 2023$2,778
+20.3%
227,115
+22.1%
0.00%0.0%
Q4 2022$2,309
-99.9%
186,049
-19.3%
0.00%
-66.7%
Q3 2022$3,149,000
+69.3%
230,542
+127.0%
0.00%
+200.0%
Q2 2022$1,860,000
+85.3%
101,552
+62.5%
0.00%0.0%
Q1 2022$1,004,000
-71.5%
62,489
-75.1%
0.00%0.0%
Q4 2021$3,520,000
+126.7%
251,292
+203.0%
0.00%0.0%
Q3 2021$1,553,000
-0.4%
82,935
+11.0%
0.00%0.0%
Q2 2021$1,559,000
-59.5%
74,746
-45.1%
0.00%
-50.0%
Q1 2021$3,852,000
+448.7%
136,202
+533.4%
0.00%
Q4 2020$702,000
-80.9%
21,504
-82.1%
0.00%
-100.0%
Q3 2020$3,681,000
+164.8%
120,146
+40.9%
0.00%
+100.0%
Q2 2020$1,390,000
+286.1%
85,278
+135.9%
0.00%
Q1 2020$360,000
-25.6%
36,148
+2.6%
0.00%
Q4 2019$484,000
+86.9%
35,225
+106.6%
0.00%
Q3 2019$259,000
-39.3%
17,049
-21.4%
0.00%
Q2 2019$427,000
+221.1%
21,679
+171.1%
0.00%
Q1 2019$133,000
-41.7%
7,996
-38.3%
0.00%
Q3 2018$228,000
+121.4%
12,965
+128.3%
0.00%
Q2 2018$103,000
-38.7%
5,680
-36.7%
0.00%
Q1 2018$168,000
+104.9%
8,977
+67.0%
0.00%
Q4 2017$82,000
+1071.4%
5,377
+1097.6%
0.00%
Q3 2017$7,000449
+3981.8%
0.00%
Q2 2017$0
-100.0%
11
-99.8%
0.00%
Q1 2017$60,0006,8000.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,766,852$57,633,0006.49%
GREAT POINT PARTNERS LLC 2,197,283$33,618,0005.74%
Sio Capital Management, LLC 392,027$5,998,0003.38%
BVF INC/IL 1,353,846$20,714,0002.50%
Boxer Capital, LLC 844,789$12,925,0002.36%
ALETHEA CAPITAL MANAGEMENT, LLC 89,673$1,372,0002.18%
Minerva Advisors LLC 170,921$2,607,0001.41%
NEXTHERA CAPITAL LP 445,550$6,817,0001.26%
DAFNA Capital Management LLC 117,281$1,794,0000.97%
PFM Health Sciences, LP 1,752,124$26,807,0000.64%
View complete list of KURA ONCOLOGY INC shareholders